Molecular genetics of human obesity: A comprehensive review

Comptes Rendus - Biologies

Volumn 340, Issue 2, 2017, Pages 87-108

  Singh, Rajan Kumar ^a   Kumar, Permendra ^a   Mahalingam, Kulandaivelu ^a  

^a VIT UNIVERSITY   (India)

Author keywords

Energy homeostasis; Epigenetics; GWAS; Obesity; ORHC

Indexed keywords

ADIPONECTIN; AGOUTI RELATED PROTEIN; BETA ADRENERGIC RECEPTOR; GHRELIN; GHRELIN RECEPTOR; INSULIN; LEPTIN; LEPTIN RECEPTOR; MELANOCORTIN; MELANOCORTIN 1 RECEPTOR; MELANOCORTIN 2 RECEPTOR; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN 5 RECEPTOR; NEUROPEPTIDE Y; PROOPIOMELANOCORTIN; PROTEIN MRAP1; PROTEIN MRAP2; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN;

BRAIN; ENERGY BALANCE; GENE; GENETIC ANALYSIS; GENOMICS; HEALTH IMPACT; HOMEOSTASIS; LITERATURE REVIEW; MOLECULAR ANALYSIS; OBESITY;

ALZHEIMER DISEASE; BARDET BIEDL SYNDROME; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM; DISEASE PREDISPOSITION; ENERGY METABOLISM; EPIGENETICS; FEEDING BEHAVIOR; FRAGILE X SYNDROME; FTO GENE; GENE; GENE LOCUS; GENE MUTATION; GENETIC DISORDER; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HYPERTENSION; INTERVERTEBRAL DISK DEGENERATION; LOW BACK PAIN; LUMBAR DISK; MALIGNANT NEOPLASM; META ANALYSIS (TOPIC); MOLECULAR GENETICS; MONOGENIC DISORDER; MULTIFACTORIAL INHERITANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OSTEOARTHRITIS; PC1 GENE; POMC GENE; PRADER WILLI SYNDROME; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHORT SURVEY; SINGLE MINDED 1 SYNDROME; SLC6A14 GENE; SYSTEMATIC REVIEW (TOPIC); WAGR SYNDROME; COMPLICATION; GENETIC PREDISPOSITION; GENETICS; MEDICAL GENETICS; METABOLISM;

ENERGY METABOLISM; GENETIC PREDISPOSITION TO DISEASE; GENETICS, MEDICAL; GENOME-WIDE ASSOCIATION STUDY; HUMANS; OBESITY;

EID: 85009471255     PISSN: 16310691     EISSN: 17683238     Source Type: Journal    
DOI: 10.1016/j.crvi.2016.11.007     Document Type: Short Survey

References (229)

1. [1] Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E.C., Biryukov, S., Abbafati, C., Abera, S.F., Abraham, J.P., Abu-Rmeileh, N.M.E., Achoki, T., AlBuhairan, F.S., Alemu, Z.A., Alfonso, R., Ali, M.K., Ali, R., Guzman, N.A., Ammar, W., Anwari, P., Banerjee, A., Barquera, S., Basu, S., Bennett, D.A., Bhutta, Z., Blore, J., Cabral, N., Nonato, I.C., Chang, J.-C., Chowdhury, R., Courville, K.J., Criqui, M.H., Cundiff, D.K., Dabhadkar, K.C., Dandona, L., Davis, A., Dayama, A., Dharmaratne, S.D., Ding, E.L., Durrani, A.M., Esteghamati, A., Farzadfar, F., Fay, D.F.J., Feigin, V.L., Flaxman, A., Forouzanfar, M.H., Goto, A., Green, M.A., Gupta, R., Hafezi-Nejad, N., Hankey, G.J., Harewood, H.C., Havmoeller, R., Hay, S., Hernandez, L., Husseini, A., Idrisov, B.T., Ikeda, N., Islami, F., Jahangir, E., Jassal, S.K., Jee, S.H., Jeffreys, M., Jonas, J.B., Kabagambe, E.K., Khalifa, S.E.A.H., Kengne, A.P., Khader, Y.S., Khang, Y.-H., Kim, D., Kimokoti, R.W., Kinge, J.M., Kokubo, Y., Kosen, S., Kwan, G., Lai, T., Leinsalu, M., Li, Y., Liang, X., Liu, S., Logroscino, G., Lotufo, P.A., Lu, Y., Ma, J., Mainoo, N.K., Mensah, G.A., Merriman, T.R., Mokdad, A.H., Moschandreas, J., Naghavi, M., Naheed, A., Nand, D., Narayan, K.M.V., Nelson, E.L., Neuhouser, M.L., Nisar, M.I., Ohkubo, T., Oti, S.O., Pedroza, A., Prabhakaran, D., Roy, N., Sampson, U., Seo, H., Sepanlou, S.G., Shibuya, K., Shiri, R., Shiue, I., Singh, G.M., Singh, J.A., Skirbekk, V., Stapelberg, N.J.C., Sturua, L., Sykes, B.L., Tobias, M., Tran, B.X., Trasande, L., Toyoshima, H., van de Vijver, S., Vasankari, T.J., Veerman, J.L., Velasquez-Melendez, G., Vlassov, V.V., Vollset, S.E., Vos, T., Wang, C., Wang, X., Weiderpass, E., Werdecker, A., Wright, J.L., Yang, Y.C., Yatsuya, H., Yoon, J., Yoon, S.-J., Zhao, Y., Zhou, M., Zhu, S., Lopez, A.D., Murray, C.J.L., Gakidou, E., Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384 (2014), 766–781, 10.1016/S0140-6736(14)60460-8.
2. [2] Kelly, T., Yang, W., Chen, C.-S., Reynolds, K., He, J., Global burden of obesity in 2005 and projections to 2030. Int. J. Obes. (Lond.) 32 (2008), 1431–1437, 10.1038/ijo.2008.102.
3. [3] Erlichman, J., Kerbey, A.L., James, W.P.T., Physical activity and its impact on health outcomes. Paper 2: Prevention of unhealthy weight gain and obesity by physical activity: an analysis of the evidence, Obes. Rev. 3 (2002), 273–287.
4. [4] Alonso, R., Farías, M., Alvarez, V., Cuevas, A., The Genetics of Obesity. Translational Cardiometabolic Genomic Medicine, Elsevier, 2016, 161–177 http://linkinghub.elsevier.com/retrieve/pii/B978012799961600007X.
5. [5] Lyon, H.N., Hirschhorn, J.N., Genetics of common forms of obesity: a brief overview. Am. J. Clin. Nutr. 82 (2005), 215S–217S.
6. [6] Scuteri, A., Sanna, S., Chen, W.-M., Uda, M., Albai, G., Strait, J., Najjar, S., Nagaraja, R., Orrú, M., Usala, G., Dei, M., Lai, S., Maschio, A., Busonero, F., Mulas, A., Ehret, G.B., Fink, A.A., Weder, A.B., Cooper, R.S., Galan, P., Chakravarti, A., Schlessinger, D., Cao, A., Lakatta, E., Abecasis, G.R., Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet., 3, 2007, e115, 10.1371/journal.pgen.0030115.
7. [7] Frayling, T.M., Timpson, N.J., Weedon, M.N., Zeggini, E., Freathy, R.M., Lindgren, C.M., Perry, J.R.B., Elliott, K.S., Lango, H., Rayner, N.W., Shields, B., Harries, L.W., Barrett, J.C., Ellard, S., Groves, C.J., Knight, B., Patch, A.-M., Ness, A.R., Ebrahim, S., Lawlor, D.A., Ring, S.M., Ben-Shlomo, Y., Jarvelin, M.-R., Sovio, U., Bennett, A.J., Melzer, D., Ferrucci, L., Loos, R.J.F., Barroso, I., Wareham, N.J., Karpe, F., Owen, K.R., Cardon, L.R., Walker, M., Hitman, G.A., Palmer, C.N.A., Doney, A.S.F., Morris, A.D., Smith, G.D., Hattersley, A.T., McCarthy, M.I., A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316 (2007), 889–894, 10.1126/science.1141634.
8. [8] Ordovas, J.M., Shen, J., Gene-Environment Interactions and Susceptibility to Metabolic Syndrome and Other Chronic Diseases. J. Periodontol. 79 (2008), 1508–1513, 10.1902/jop.2008.080232.
9. [9] Bird, A., Perceptions of epigenetics. Nature 447 (2007), 396–398, 10.1038/nature05913.
10. [10] Barres, R., Zierath, J.R., DNA methylation in metabolic disorders. Am. J. Clin. Nutr. 93 (2011), 897S–900S, 10.3945/ajcn.110.001933.
11. [11] Campión, J., Milagro, F.I., Martínez, J.A., Individuality and epigenetics in obesity. Obes. Rev. 10 (2009), 383–392, 10.1111/j.1467-789X.2009.00595.x.
12. [12] Dolinoy, D.C., Jirtle, R.L., Environmental epigenomics in human health and disease. Environ. Mol. Mutagen. 49 (2008), 4–8, 10.1002/em.20366.
13. [13] Hetherington, A.W., Ranson, S.W., Hypothalamic lesions and adiposity in the rat. Anat. Rec. 78 (1940), 149–172, 10.1002/ar.1090780203.
14. [14] Geary, N., Pancreatic glucagon signals postprandial satiety. Neurosci. Biobehav. Rev. 14 (1990), 323–338.
15. [15] Gibbs, J., Fauser, D.J., Rowe, E.A., Rolls, B.J., Rolls, E.T., Maddison, S.P., Bombesin suppresses feeding in rats. Nature (Lond.) 282 (1979), 208–210.
16. [16] Friedman, J.M., Halaas, J.L., Leptin and the regulation of body weight in mammals. Nature (Lond.) 395 (1998), 763–770.
17. [17] Minokoshi, Y., Kim, Y.-B., Peroni, O.D., Fryer, L.G.D., Müller, C., Carling, D., Kahn, B.B., Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415 (2002), 339–343, 10.1038/415339a.
18. [18] Donoso, M.A., Munoz-Calvo, M.T., Barrios, V., Garrido, G., Hawkins, F., Argente, J., Increased circulating adiponectin levels and decreased leptin/soluble leptin receptor ratio throughout puberty in female ballet dancers: association with body composition and the delay in puberty. Eur. J. Endocrinol. 162 (2010), 905–911, 10.1530/EJE-09-0874.
19. [19] Barkan, D., Jia, H., Dantes, A., Vardimon, L., Amsterdam, A., Rubinstein, M., Leptin modulates the glucocorticoid-induced ovarian steroidogenesis. Endocrinology 140 (1999), 1731–1738, 10.1210/endo.140.4.6614.
20. [20] Matarese, G., Procaccini, C., De Rosa, V., Horvath, T.L., La Cava, A., Regulatory T cells in obesity: the leptin connection. Trends. Mol. Med. 16 (2010), 247–256, 10.1016/j.molmed.2010.04.002.
21. [21] Tartaglia, L.A., Dembski, M., Weng, X., Deng, N., Culpepper, J., Devos, R., Richards, G.J., Campfield, L.A., Clark, F.T., Deeds, J., Muir, C., Sanker, S., Moriarty, A., Moore, K.J., Smutko, J.S., Mays, G.G., Wool, E.A., Monroe, C.A., Tepper, R.I., Identification and expression cloning of a leptin receptor, OB-R. Cell 83 (1995), 1263–1271.
22. [22] Myers, M.G., Cowley, M.A., Münzberg, H., Mechanisms of leptin action and leptin resistance. Annu. Rev. Physiol. 70 (2008), 537–556, 10.1146/annurev.physiol.70.113006.100707.
23. [23] Chavez, M., Seeley, R.J., Woods, S.C., A comparison between effects of intraventricular insulin and intraperitoneal lithium chloride on three measures sensitive to emetic agents. Behav. Neurosci. 109 (1995), 547–550.
24. [24] Ceperuelo-Mallafré, V., Ejarque, M., Serena, C., Duran, X., Montori-Grau, M., Rodríguez, M.A., Yanes, O., Núñez-Roa, C., Roche, K., Puthanveetil, P., Garrido-Sánchez, L., Saez, E., Tinahones, F.J., Garcia-Roves, P.M., Gómez-Foix, A.M., Saltiel, A.R., Vendrell, J., Fernández-Veledo, S., Adipose tissue glycogen accumulation is associated with obesity-linked inflammation in humans. Mol. Metabol. 5 (2015), 5–18, 10.1016/j.molmet.2015.10.001.
25. [25] Aboouf, M.A., Hamdy, N.M., Amin, A.I., El-Mesallamy, H.O., Genotype screening of APLN rs3115757 variant in Egyptian women population reveals an association with obesity and insulin resistance. Diabetes Res. Clin. Pract. 109 (2015), 40–47, 10.1016/j.diabres.2015.05.016.
26. [26] Olza, J., Gil-Campos, M., Leis, R., Rupérez, A.I., Tojo, R., Cañete, R., Gil, Á., Aguilera, C.M., Influence of variants in the NPY gene on obesity and metabolic syndrome features in Spanish children. Peptides 45 (2013), 22–27, 10.1016/j.peptides.2013.04.007.
27. [27] Vettor, R., Zarjevski, N., Cusin, I., Rohner-Jeanrenaud, F., Jeanrenaud, B., Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats. Diabetologia 37 (1994), 1202–1208.
28. [28] Jackson, P.J., Douglas, N.R., Chai, B., Binkley, J., Sidow, A., Barsh, G.S., Millhauser, G.L., Structural and molecular evolutionary analysis of Agouti and Agouti-related proteins. Chem. Biol. 13 (2006), 1297–1305, 10.1016/j.chembiol.2006.10.006.
29. [29] Yang, Y.K., Ollmann, M.M., Wilson, B.D., Dickinson, C., Yamada, T., Barsh, G.S., Gantz, I., Effects of recombinant agouti-signaling protein on melanocortin action. Mol. Endocrinol. 11 (1997), 274–280, 10.1210/mend.11.3.9898.
30. [30] Lu, D., Willard, D., Patel, I.R., Kadwell, S., Overton, L., Kost, T., Luther, M., Chen, W., Woychik, R.P., Wilkison, W.O., Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 371 (1994), 799–802, 10.1038/371799a0.
31. [31] Pritchard, L.E., Turnbull, A.V., White, A., Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity. J. Endocrinol. 172 (2002), 411–421.
32. [32] Heilbronn, L.K., Smith, S.R., Ravussin, E., The insulin-sensitizing role of the fat derived hormone adiponectin. Curr. Pharm. Design 9 (2003), 1411–1418.
33. [33] Gale, S.M., Castracane, V.D., Mantzoros, C.S., Energy homeostasis, obesity and eating disorders: recent advances in endocrinology. J. Nutr. 134 (2004), 295–298.
34. [34] Girardet, C., Butler, A.A., Neural melanocortin receptors in obesity and related metabolic disorders. Biochim. Biophys. Acta. 1842 (2014), 482–494, 10.1016/j.bbadis.2013.05.004.
35. [35] Rodrigues, A.R., Almeida, H., Gouveia, A.M., Intracellular signaling mechanisms of the melanocortin receptors: current state of the art. Cell. Mol. Life Sci. 72 (2015), 1331–1345, 10.1007/s00018-014-1800-3.
36. [36] Garfield, A.S., Lam, D.D., Marston, O.J., Przydzial, M.J., Heisler, L.K., Role of central melanocortin pathways in energy homeostasis. Trends Endocrinol. Metab. 20 (2009), 203–215, 10.1016/j.tem.2009.02.002.
37. [37] Leibel, R.L., The molecular genetics of the melanocortin pathway and energy homeostasis. Cell Metab. 3 (2006), 79–81, 10.1016/j.cmet.2006.01.010.
38. [38] Lee, Y.S., Challis, B.G., Thompson, D.A., Yeo, G.S.H., Keogh, J.M., Madonna, M.E., Wraight, V., Sims, M., Vatin, V., Meyre, D., Shield, J., Burren, C., Ibrahim, Z., Cheetham, T., Swift, P., Blackwood, A., Hung, C.-C.C., Wareham, N.J., Froguel, P., Millhauser, G.L., O'Rahilly, S., Farooqi, I.S., A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance. Cell Metab. 3 (2006), 135–140, 10.1016/j.cmet.2006.01.006.
39. [39] Biebermann, H., Castañeda, T.R., van Landeghem, F., von Deimling, A., Escher, F., Brabant, G., Hebebrand, J., Hinney, A., Tschöp, M.H., Grüters, A., Krude, H., A role for beta-melanocyte-stimulating hormone in human body-weight regulation. Cell Metab. 3 (2006), 141–146, 10.1016/j.cmet.2006.01.007.
40. [40] Tao, Y.-X., Molecular mechanisms of the neural melanocortin receptor dysfunction in severe early onset obesity. Mol. Cell. Endocrinol. 239 (2005), 1–14, 10.1016/j.mce.2005.04.012.
41. [41] Cooray, S.N., Clark, A.J.L., Melanocortin receptors and their accessory proteins. Mol. Cell. Endocrinol. 331 (2011), 215–221, 10.1016/j.mce.2010.07.015.
42. [42] Williams, K.W., Scott, M.M., Elmquist, J.K., Modulation of the central melanocortin system by leptin, insulin, and serotonin: co-ordinated actions in a dispersed neuronal network. Eur. J. Pharmacol. 660 (2011), 2–12, 10.1016/j.ejphar.2010.11.042.
43. [43] Chhajlani, V., Wikberg, J.E., Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett. 309 (1992), 417–420.
44. [44] Mountjoy, K.G., Robbins, L.S., Mortrud, M.T., Cone, R.D., The cloning of a family of genes that encode the melanocortin receptors. Science 257 (1992), 1248–1251.
45. [45] Mountjoy, K.G., Mortrud, M.T., Low, M.J., Simerly, R.B., Cone, R.D., Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol. Endocrinol. 8 (1994), 1298–1308, 10.1210/mend.8.10.7854347.
46. [46] Gantz, I., Konda, Y., Tashiro, T., Shimoto, Y., Miwa, H., Munzert, G., Watson, S.J., DelValle, J., Yamada, T., Molecular cloning of a novel melanocortin receptor. J. Biol. Chem. 268 (1993), 8246–8250.
47. [47] Gantz, I., Miwa, H., Konda, Y., Shimoto, Y., Tashiro, T., Watson, S.J., DelValle, J., Yamada, T., Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J. Biol. Chem. 268 (1993), 15174–15179.
48. [48] Gantz, I., Shimoto, Y., Konda, Y., Miwa, H., Dickinson, C.J., Yamada, T., Molecular cloning, expression, and characterization of a fifth melanocortin receptor, Biochem. Biophys. Res. Commun. 200 (1994), 1214–1220, 10.1006/bbrc.1994.1580.
49. [49] Roselli-Rehfuss, L., Mountjoy, K.G., Robbins, L.S., Mortrud, M.T., Low, M.J., Tatro, J.B., Entwistle, M.L., Simerly, R.B., Cone, R.D., Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc. Natl. Acad. Sci. U.S.A. 90 (1993), 8856–8860.
50. [50] Chan, L.F., Webb, T.R., Chung, T.-T., Meimaridou, E., Cooray, S.N., Guasti, L., Chapple, J.P., Egertova, M., Elphick, M.R., Cheetham, M.E., Metherell, L.A., Clark, A.J.L., MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 6146–6151, 10.1073/pnas.0809918106.
51. [51] Begriche, K., Levasseur, P.R., Zhang, J., Rossi, J., Skorupa, D., Solt, L.A., Young, B., Burris, T.P., Marks, D.L., Mynatt, R.L., Butler, A.A., Genetic Dissection of the Functions of the Melanocortin-3 Receptor, a Seven-transmembrane G-protein-coupled Receptor Suggests Roles for Central and Peripheral Receptors in Energy Homeostasis. J. Biol. Chem. 286 (2011), 40771–40781, 10.1074/jbc.M111.278374.
52. [52] Herraiz, C., Journé, F., Ghanem, G., Jiménez-Cervantes, C., García-Borrón, J.C., Functional status and relationships of melanocortin 1 receptor signaling to the cAMP and extracellular signal-regulated protein kinases 1 and 2 pathways in human melanoma cells. Int. J. Biochem. Cell Biol. 44 (2012), 2244–2252, 10.1016/j.biocel.2012.09.008.
53. [53] Gillbro, J.M., Olsson, M.J., The melanogenesis and mechanisms of skin-lightening agents - existing and new approaches: Melanogenesis and skin-lightening agents. Int. J. Cosmet. Sci. 33 (2011), 210–221, 10.1111/j.1468-2494.2010.00616.x.
54. [54] Catania, A., Gatti, S., Colombo, G., Lipton, J.M., Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol. Rev. 56 (2004), 1–29 doi:10.1124/pr.56.1.1.
55. [55] Ollmann, M.M., Wilson, B.D., Yang, Y.K., Kerns, J.A., Chen, Y., Gantz, I., Barsh, G.S., Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278 (1997), 135–138.
56. [56] Tatro, J.B., Atkins, M., Mier, J.W., Hardarson, S., Wolfe, H., Smith, T., Entwistle, M.L., Reichlin, S., Melanotropin receptors demonstrated in situ in human melanoma. J. Clin. Invest. 85 (1990), 1825–1832, 10.1172/JCI114642.
57. [57] Chida, D., Nakagawa, S., Nagai, S., Sagara, H., Katsumata, H., Imaki, T., Suzuki, H., Mitani, F., Ogishima, T., Shimizu, C., Kotaki, H., Kakuta, S., Sudo, K., Koike, T., Kubo, M., Iwakura, Y., Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 18205–18210, 10.1073/pnas.0706953104.
58. [58] Lee, M., Kim, A., Conwell, I.M., Hruby, V., Mayorov, A., Cai, M., Wardlaw, S.L., Effects of selective modulation of the central melanocortin-3-receptor on food intake and hypothalamic POMC expression. Peptides 29 (2008), 440–447, 10.1016/j.peptides.2007.11.005.
59. [59] Sutton, G.M., Perez-Tilve, D., Nogueiras, R., Fang, J., Kim, J.K., Cone, R.D., Gimble, J.M., Tschop, M.H., Butler, A.A., The Melanocortin-3 Receptor Is Required for Entrainment to Meal Intake. J. Neurosci. 28 (2008), 12946–12955, 10.1523/JNEUROSCI.3615-08.2008.
60. [60] Tao, Y.-X., The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology. Endocr. Rev. 31 (2010), 506–543, 10.1210/er.2009-0037.
61. [61] Lasaga, M., Debeljuk, L., Durand, D., Scimonelli, T.N., Caruso, C., Role of α-melanocyte stimulating hormone and melanocortin 4 receptor in brain inflammation. Peptides 29 (2008), 1825–1835, 10.1016/j.peptides.2008.06.009.
62. [62] Selkirk, J.V., Nottebaum, L.M., Lee, J., Yang, W., Foster, A.C., Lechner, S.M., Identification of differential melanocortin 4 receptor agonist profiles at natively expressed receptors in rat cortical astrocytes and recombinantly expressed receptors in human embryonic kidney cells. Neuropharmacology 52 (2007), 459–466, 10.1016/j.neuropharm.2006.08.015.
63. [63] Caruso, C., Durand, D., Schiöth, H.B., Rey, R., Seilicovich, A., Lasaga, M., Activation of melanocortin 4 receptors reduces the inflammatory response and prevents apoptosis induced by lipopolysaccharide and interferon-gamma in astrocytes. Endocrinology 148 (2007), 4918–4926, 10.1210/en.2007-0366.
64. [64] Van der Ploeg, L.H.T., Martin, W.J., Howard, A.D., Nargund, R.P., Austin, C.P., Guan, X., Drisko, J., Cashen, D., Sebhat, I., Patchett, A.A., Figueroa, D.J., DiLella, A.G., Connolly, B.M., Weinberg, D.H., Tan, C.P., Palyha, O.C., Pong, S.-S., MacNeil, T., Rosenblum, C., Vongs, A., Tang, R., Yu, H., Sailer, A.W., Fong, T.M., Huang, C., Tota, M.R., Chang, R.S., Stearns, R., Tamvakopoulos, C., Christ, G., Drazen, D.L., Spar, B.D., Nelson, R.J., MacIntyre, D.E., A role for the melanocortin 4 receptor in sexual function. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 11381–11386, 10.1073/pnas.172378699.
65. [65] Rodrigues, A.R., Pignatelli, D., Almeida, H., Gouveia, A.M., Melanocortin 5 receptor activates ERK1/2 through a PI3K-regulated signaling mechanism. Mol. Cell. Endocrinol. 303 (2009), 74–81, 10.1016/j.mce.2009.01.014.
66. [66] An, J.J., Rhee, Y., Kim, S.H., Kim, D.M., Han, D.-H., Hwang, J.H., Jin, Y.-J., Cha, B.S., Baik, J.-H., Lee, W.T., Lim, S.-K., Peripheral effect of alpha-melanocyte-stimulating hormone on fatty acid oxidation in skeletal muscle. J. Biol. Chem. 282 (2007), 2862–2870, 10.1074/jbc.M603454200.
67. [67] Chen, W., Kelly, M.A., Opitz-Araya, X., Thomas, R.E., Low, M.J., Cone, R.D., Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides. Cell 91 (1997), 789–798.
68. [68] Hill, J.O., Wyatt, H.R., Peters, J.C., Energy Balance and Obesity. Circulation 126 (2012), 126–132, 10.1161/CIRCULATIONAHA.111.087213.
69. [69] McNulty, J.C., Jackson, P.J., Thompson, D.A., Chai, B., Gantz, I., Barsh, G.S., Dawson, P.E., Millhauser, G.L., Structures of the agouti signaling protein. J. Mol. Biol. 346 (2005), 1059–1070, 10.1016/j.jmb.2004.12.030.
70. [70] Fan, W., Boston, B.A., Kesterson, R.A., Hruby, V.J., Cone, R.D., Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385 (1997), 165–168, 10.1038/385165a0.
71. [71] Feng, N., Young, S.F., Aguilera, G., Puricelli, E., Adler-Wailes, D.C., Sebring, N.G., Yanovski, J.A., Co-occurrence of two partially inactivating polymorphisms of MC3R is associated with pediatric-onset obesity. Diabetes 54 (2005), 2663–2667.
72. [72] Lee, J.H., Reed, D.R., Li, W.D., Xu, W., Joo, E.J., Kilker, R.L., Nanthakumar, E., North, M., Sakul, H., Bell, C., Price, R.A., Genome scan for human obesity and linkage to markers in 20q13. Am. J. Hum. Genet. 64 (1999), 196–209, 10.1086/302195.
73. [73] Lembertas, A.V., Pérusse, L., Chagnon, Y.C., Fisler, J.S., Warden, C.H., Purcell-Huynh, D.A., Dionne, F.T., Gagnon, J., Nadeau, A., Lusis, A.J., Bouchard, C., Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q. J. Clin. Invest. 100 (1997), 1240–1247, 10.1172/JCI119637.
74. [74] Butler, A.A., Marks, D.L., Fan, W., Kuhn, C.M., Bartolome, M., Cone, R.D., Melanocortin-4 receptor is required for acute homeostatic responses to increased dietary fat. Nat. Neurosci. 4 (2001), 605–611 doi:10.1038/88423.
75. [75] Cowley, M.A., Smart, J.L., Rubinstein, M., Cerdán, M.G., Diano, S., Horvath, T.L., Cone, R.D., Low, M.J., Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411 (2001), 480–484, 10.1038/35078085.
76. [76] Spiegelman, B.M., Flier, J.S., Obesity and the regulation of energy balance. Cell 104 (2001), 531–543.
77. [77] Fontaine, K.R., Redden, D.T., Wang, C., Westfall, A.O., Allison, D.B., Years of life lost due to obesity. JAMA 289 (2003), 187–193.
78. [78] van der Leeuw, J., van der Graaf, Y., Nathoe, H.M., de Borst, G.J., Kappelle, L.J., Visseren, F.L.J., van Petersen, R., Pijl, A.G., Algra, A., van der Graaf, Y., Grobbee, D.E., Rutten, G.E.H.M., Visseren, F.L.J., Moll, F.L., Kappelle, L.J., Mali, W.P.T.M., Doevendans, P.A., On behalf of the SMART study group. The separate and combined effects of adiposity and cardiometabolic dysfunction on the risk of recurrent cardiovascular events and mortality in patients with manifest vascular disease. Heart 100 (2014), 1421–1429, 10.1136/heartjnl-2014-305490.
79. [79] McCrindle, B.W., Cardiovascular Consequences of Childhood Obesity. Can. J. Cardiol. 31 (2015), 124–130, 10.1016/j.cjca.2014.08.017.
80. [80] Kotsis, V., Stabouli, S., Papakatsika, S., Rizos, Z., Parati, G., Mechanisms of obesity-induced hypertension. Hypertens. Res. 33 (2010), 386–393, 10.1038/hr.2010.9.
81. [81] Re, R.N., Obesity-related hypertension. Ochsner J. 9 (2009), 133–136.
82. [82] Power, C., Pinto Pereira, S.M., Law, C., Ki, M., Obesity and risk factors for cardiovascular disease and type 2 diabetes: investigating the role of physical activity and sedentary behaviour in mid-life in the 1958 British cohort. Atherosclerosis 233 (2014), 363–369, 10.1016/j.atherosclerosis.2014.01.032.
83. [83] Visser, A., Ioan-Facsinay, A., de Mutsert, R., Widya, R.L., Loef, M., de Roos, A., le Cessie, S., den Heijer, M., Rosendaal, F.R., Kloppenburg, M., NEO Study Group. Adiposity and hand osteoarthritis: the Netherlands Epidemiology of Obesity study. Arthritis Res. Ther., 16, 2014, R19 doi:10.1186/ar4447.
84. [84] Luchsinger, J.A., Cheng, D., Tang, M.X., Schupf, N., Mayeux, R., Central obesity in the elderly is related to late-onset Alzheimer disease. Alzheimer Dis. Assoc. Disord. 26 (2012), 101–105, 10.1097/WAD.0b013e318222f0d4.
85. [85] Oberman, B., Khaku, A., Camacho, F., Goldenberg, D., Relationship between obesity, diabetes and the risk of thyroid cancer, Am. J. Otolaryngol. 36 (2015), 535–541, 10.1016/j.amjoto.2015.02.015.
86. [86] Benedetto, C., Salvagno, F., Canuto, E.M., Gennarelli, G., Obesity and female malignancies. Best Pract. Res. Clin. Obstet. Gynaecol. 29 (2015), 528–540, 10.1016/j.bpobgyn.2015.01.003.
87. [87] Agalliu, I., Williams, S., Adler, B., Androga, L., Siev, M., Lin, J., Xue, X., Huang, G., Strickler, H.D., Ghavamian, R., The impact of obesity on prostate cancer recurrence observed after exclusion of diabetics. Cancer Causes Control. 26 (2015), 821–830, 10.1007/s10552-015-0554-z.
88. [88] Wasserman, L., Flatt, S.W., Natarajan, L., Laughlin, G., Matusalem, M., Faerber, S., Rock, C.L., Barrett-Connor, E., Pierce, J.P., Correlates of obesity in postmenopausal women with breast cancer: comparison of genetic, demographic, disease-related, life history and dietary factors. Int. J. Obes. Relat. Metab. Disord. 28 (2004), 49–56, 10.1038/sj.ijo.0802481.
89. [89] Dario, A.B., Ferreira, M.L., Refshauge, K.M., Lima, T.S., Ordoñana, J.R., Ferreira, P.H., The relationship between obesity, low back pain, and lumbar disc degeneration when genetics and the environment are considered: a systematic review of twin studies. Spine J. 15 (2015), 1106–1117, 10.1016/j.spinee.2015.02.001.
90. [90] Shiri, R., Karppinen, J., Leino-Arjas, P., Solovieva, S., Viikari-Juntura, E., The Association Between Obesity and Low Back Pain: A Meta-Analysis. Am. J. Epidemiol. 171 (2010), 135–154, 10.1093/aje/kwp356.
91. [91] Poirier, P., Giles, T.D., Bray, G.A., Hong, Y., Stern, J.S., Pi-Sunyer, F.X., Eckel, R.H., American Heart Association, Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 113 (2006), 898–918, 10.1161/CIRCULATIONAHA.106.171016.
92. [92] Poirier, P., Després, J.P., Exercise in weight management of obesity. Cardiol. Clin. 19 (2001), 459–470.
93. [93] Kasper, E.K., Hruban, R.H., Baughman, K.L., Cardiomyopathy of obesity: a clinicopathologic evaluation of 43 obese patients with heart failure. Am. J. Cardiol. 70 (1992), 921–924.
94. [94] Mozaffarian, D., Benjamin, E.J., Go, A.S., Arnett, D.K., Blaha, M.J., Cushman, M., de Ferranti, S., Després, J.-P., Fullerton, H.J., Howard, V.J., Huffman, M.D., Judd, S.E., Kissela, B.M., Lackland, D.T., Lichtman, J.H., Lisabeth, L.D., Liu, S., Mackey, R.H., Matchar, D.B., McGuire, D.K., Mohler, E.R., Moy, C.S., Muntner, P., Mussolino, M.E., Nasir, K., Neumar, R.W., Nichol, G., Palaniappan, L., Pandey, D.K., Reeves, M.J., Rodriguez, C.J., Sorlie, P.D., Stein, J., Towfighi, A., Turan, T.N., Virani, S.S., Willey, J.Z., Woo, D., Yeh, R.W., Turner, M.B., On bhalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, 2015. Heart Disease and Stroke Statistics – 2015 Update: A Report From the American Heart Association. Circulation 131 (2015), e29–e322, 10.1161/CIR.0000000000000152.
95. [95] Hubert, H.B., Feinleib, M., McNamara, P.M., Castelli, W.P., Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 67 (1983), 968–977.
96. [96] Rabkin, S.W., Mathewson, F.A., Hsu, P.H., Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26-year observation period: the Manitoba Study. Am. J. Cardiol. 39 (1977), 452–458.
97. [97] Romero-Corral, A., Montori, V.M., Somers, V.K., Korinek, J., Thomas, R.J., Allison, T.G., Mookadam, F., Lopez-Jimenez, F., Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet 368 (2006), 666–678, 10.1016/S0140-6736(06)69251-9.
98. [98] Das, S.R., Alexander, K.P., Chen, A.Y., Powell-Wiley, T.M., Diercks, D.B., Peterson, E.D., Roe, M.T., de Lemos, J.A., Impact of Body Weight and Extreme Obesity on the Presentation, Treatment, and In-Hospital Outcomes of 50,149 Patients With ST-Segment Elevation Myocardial Infarction. J. Am. Coll. Cardiol. 58 (2011), 2642–2650, 10.1016/j.jacc.2011.09.030.
99. [99] Dhoot, J., Tariq, S., Erande, A., Amin, A., Patel, P., Malik, S., Effect of Morbid Obesity on In-Hospital Mortality and Coronary Revascularization Outcomes After Acute Myocardial Infarction in the United States. Am. J. Cardiol. 111 (2013), 1104–1110, 10.1016/j.amjcard.2012.12.033.
100. [100] Kearney, P.M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P.K., He, J., Global burden of hypertension: analysis of worldwide data. Lancet 365 (2005), 217–223, 10.1016/S0140-6736(05)17741-1.
101. [101] Zhang, R., Reisin, E., Obesity-hypertension: the effects on cardiovascular and renal systems. Am. J. Hypertens. 13 (2000), 1308–1314.
102. [102] Hall, J.E., Crook, E.D., Jones, D.W., Wofford, M.R., Dubbert, P.M., Mechanisms of obesity-associated cardiovascular and renal disease. Am. J. Med. Sci. 324 (2002), 127–137.
103. [103] Hall, J.E., Pathophysiology of obesity hypertension. Curr. Hypertens. Rep. 2 (2000), 139–147.
104. [104] Wofford, M.R., Hall, J.E., Pathophysiology and treatment of obesity hypertension. Curr. Pharm. Des. 10 (2004), 3621–3637.
105. [105] Frohlich, E.D., Clinical management of the obese hypertensive patient. Cardiol. Rev. 10 (2002), 127–138, 10.1097/01.CRD.0000016502.68768.4C.
106. [106] Kannel, W.B., Garrison, R.J., Dannenberg, A.L., Secular blood pressure trends in normotensive persons: the Framingham Study. Am. Heart J. 125 (1993), 1154–1158.
107. [107] Padmanabhan, S., Newton-Cheh, C., Dominiczak, A.F., Genetic basis of blood pressure and hypertension. Trends Genet. 28 (2012), 397–408, 10.1016/j.tig.2012.04.001.
108. [108] Väremo, L., Nookaew, I., Nielsen, J., Novel insights into obesity and diabetes through genome-scale metabolic modeling. Front. Physiol., 4, 2013, 10.3389/fphys.2013.00092.
109. [109] Golay, A., Ybarra, J., Link between obesity and type 2 diabetes. Best Pract. Res. Clin. Endocrinol. Metab. 19 (2005), 649–663, 10.1016/j.beem.2005.07.010.
110. [110] Zimmet, P., Alberti, K.G., Shaw, J., Global and societal implications of the diabetes epidemic. Nature 414 (2001), 782–787, 10.1038/414782a.
111. [111] Whiting, D.R., Guariguata, L., Weil, C., Shaw, J., IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res. Clin. Pract. 94 (2011), 311–321, 10.1016/j.diabres.2011.10.029.
112. [112] Scully, T., Diabetes in numbers. Nature 485 (2012), S2–S3.
113. [113] Stumvoll, M., Goldstein, B.J., van Haeften, T.W., Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365 (2005), 1333–1346, 10.1016/S0140-6736(05)61032-X.
114. [114] Halpern, A., Mancini, M.C., Diabesity: are weight loss medications effective?. Treat. Endocrinol. 4 (2005), 65–74.
115. [115] Warram, J.H., Martin, B.C., Krolewski, A.S., Soeldner, J.S., Kahn, C.R., Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann. Intern. Med. 113 (1990), 909–915.
116. [116] Yusuf, E., Nelissen, R.G., Ioan-Facsinay, A., Stojanovic-Susulic, V., DeGroot, J., van Osch, G., Middeldorp, S., Huizinga, T.W.J., Kloppenburg, M., Association between weight or body mass index and hand osteoarthritis: a systematic review. Ann. Rheum. Dis. 69 (2010), 761–765, 10.1136/ard.2008.106930.
117. [117] Teichtahl, A.J., Wang, Y., Wluka, A.E., Cicuttini, F.M., Obesity and Knee Osteoarthritis: New Insights Provided by Body Composition Studies. Obesity 16 (2008), 232–240, 10.1038/oby.2007.30.
118. [118] Holliday, K.L., McWilliams, D.F., Maciewicz, R.A., Muir, K.R., Zhang, W., Doherty, M., Lifetime body mass index, other anthropometric measures of obesity and risk of knee or hip osteoarthritis in the GOAL case-control study. Osteoarthr. Cartil. 19 (2011), 37–43, 10.1016/j.joca.2010.10.014.
119. [119] Sowers, M.F., Yosef, M., Jamadar, D., Jacobson, J., Karvonen-Gutierrez, C., Jaffe, M., BMI vs. body composition and radiographically defined osteoarthritis of the knee in women: a 4-year follow-up study. Osteoarthr. Cartil. 16 (2008), 367–372, 10.1016/j.joca.2007.07.016.
120. [120] Hamdy, O., Porramatikul, S., Al-Ozairi, E., Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr. Diabetes Rev. 2 (2006), 367–373.
121. [121] Pottie, P., Presle, N., Terlain, B., Netter, P., Mainard, D., Berenbaum, F., Obesity and osteoarthritis: more complex than predicted!. Ann. Rheum. Dis. 65 (2006), 1403–1405, 10.1136/ard.2006.061994.
122. [122] Ritchie, K., Lovestone, S., The dementias. Lancet 360 (2002), 1759–1766, 10.1016/S0140-6736(02)11667-9.
123. [123] Fitzpatrick, A.L., Kuller, L.H., Lopez, O.L., Diehr, P., O'Meara, E.S., Longstreth, W.T., Luchsinger, J.A., Midlife and Late-Life Obesity and the Risk of Dementia: Cardiovascular Health Study. Arch. Neurol., 66, 2009, 10.1001/archneurol.2008.582.
124. [124] Whitmer, R.A., Gustafson, D.R., Barrett-Connor, E., Haan, M.N., Gunderson, E.P., Yaffe, K., Central obesity and increased risk of dementia more than three decades later. Neurology 71 (2008), 1057–1064, 10.1212/01.wnl.0000306313.89165.ef.
125. [125] Kivipelto, M., Ngandu, T., Fratiglioni, L., Viitanen, M., Kåreholt, I., Winblad, B., Helkala, E.-L., Tuomilehto, J., Soininen, H., Nissinen, A., Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch. Neurol. 62 (2005), 1556–1560, 10.1001/archneur.62.10.1556.
126. [126] Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., Lisheng, L., INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004), 937–952, 10.1016/S0140-6736(04)17018-9.
127. [127] Siegel, R., Ma, J., Zou, Z., Jemal, A., Cancer statistics, 2014. CA Cancer J. Clin. 64 (2014), 9–29, 10.3322/caac.21208.
128. [128] N. Howlader, A. Noone, M. Krapcho, J. Garshell, D. Miller, S. Altekruse et al. 2014, SEER cancer statistics review, 1975-2011. National Cancer Institute, Bethesda, MD. http://seer.cancer.gov/csr/1975_2011/. Based on November 2013 SEER data submission, posted to the SEER web site, April 2014.
129. [129] Wang, T., Ma, X., Peng, D., Zhang, R., Sun, X., Chen, M., Yan, J., Wang, S., Yan, D., He, Z., Jiang, F., Bao, Y., Hu, C., Jia, W., Effects of Obesity Related Genetic Variations on Visceral and Subcutaneous Fat Distribution in a Chinese Population. Sci. Rep., 6, 2016, 20691, 10.1038/srep20691.
130. [130] Brookheart, R.T., Duncan, J.G., Drosophila melanogaster: An emerging model of transgenerational effects of maternal obesity. Mol. Cell Endocrinol. 435 (2016), 20–28, 10.1016/j.mce.2015.12.003.
131. [131] Farooqi, I.S., O'Rahilly, S., Genetic Syndromes Associated with Obesity. Jameson, J.L., De Groot, L.J., (eds.) Endocrinology: Adult and Pediatric, 7th Edition, 2016, Saunders, Elsevier, 491–497e2 http://linkinghub.elsevier.com/retrieve/pii/B9780323189071000287.
132. [132] Hindorff, L.A., Sethupathy, P., Junkins, H.A., Ramos, E.M., Mehta, J.P., Collins, F.S., Manolio, T.A., Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 9362–9367, 10.1073/pnas.0903103106.
133. [133] Kilpeläinen, T.O., Qi, L., Brage, S., Sharp, S.J., Sonestedt, E., Demerath, E., Ahmad, T., Mora, S., Kaakinen, M., Sandholt, C.H., Holzapfel, C., Autenrieth, C.S., Hyppönen, E., Cauchi, S., He, M., Kutalik, Z., Kumari, M., Stančáková, A., Meidtner, K., Balkau, B., Tan, J.T., Mangino, M., Timpson, N.J., Song, Y., Zillikens, M.C., Jablonski, K.A., Garcia, M.E., Johansson, S., Bragg-Gresham, J.L., Wu, Y., van Vliet-Ostaptchouk, J.V., Onland-Moret, N.C., Zimmermann, E., Rivera, N.V., Tanaka, T., Stringham, H.M., Silbernagel, G., Kanoni, S., Feitosa, M.F., Snitker, S., Ruiz, J.R., Metter, J., Larrad, M.T.M., Atalay, M., Hakanen, M., Amin, N., Cavalcanti-Proença, C., Grøntved, A., Hallmans, G., Jansson, J.-O., Kuusisto, J., Kähönen, M., Lutsey, P.L., Nolan, J.J., Palla, L., Pedersen, O., Pérusse, L., Renström, F., Scott, R.A., Shungin, D., Sovio, U., Tammelin, T.H., Rönnemaa, T., Lakka, T.A., Uusitupa, M., Rios, M.S., Ferrucci, L., Bouchard, C., Meirhaeghe, A., Fu, M., Walker, M., Borecki, I.B., Dedoussis, G.V., Fritsche, A., Ohlsson, C., Boehnke, M., Bandinelli, S., van Duijn, C.M., Ebrahim, S., Lawlor, D.A., Gudnason, V., Harris, T.B., Sørensen, T.I.A., Mohlke, K.L., Hofman, A., Uitterlinden, A.G., Tuomilehto, J., Lehtimäki, T., Raitakari, O., Isomaa, B., Njølstad, P.R., Florez, J.C., Liu, S., Ness, A., Spector, T.D., Tai, E.S., Froguel, P., Boeing, H., Laakso, M., Marmot, M., Bergmann, S., Power, C., Khaw, K.-T., Chasman, D., Ridker, P., Hansen, T., Monda, K.L., Illig, T., Järvelin, M.-R., Wareham, N.J., Hu, F.B., Groop, L.C., Orho-Melander, M., Ekelund, U., Franks, P.W., Loos, R.J.F., Physical Activity Attenuates the Influence of FTO Variants on Obesity Risk: A Meta-Analysis of 218,166 Adults and 19,268 Children. PLoS Med., 8, 2011, e1001116, 10.1371/journal.pmed.1001116.
134. [134] Meyre, D., Delplanque, J., Chèvre, J.-C., Lecoeur, C., Lobbens, S., Gallina, S., Durand, E., Vatin, V., Degraeve, F., Proença, C., Gaget, S., Körner, A., Kovacs, P., Kiess, W., Tichet, J., Marre, M., Hartikainen, A.-L., Horber, F., Potoczna, N., Hercberg, S., Levy-Marchal, C., Pattou, F., Heude, B., Tauber, M., McCarthy, M.I., Blakemore, A.I.F., Montpetit, A., Polychronakos, C., Weill, J., Coin, L.J.M., Asher, J., Elliott, P., Järvelin, M.-R., Visvikis-Siest, S., Balkau, B., Sladek, R., Balding, D., Walley, A., Dina, C., Froguel, P., Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations. Nat. Genet. 41 (2009), 157–159 doi:10.1038/ng.301.
135. [135] Chambers, J.C., Elliott, P., Zabaneh, D., Zhang, W., Li, Y., Froguel, P., Balding, D., Scott, J., Kooner, J.S., Common genetic variation near MC4R is associated with waist circumference and insulin resistance. Nat. Genet. 40 (2008), 716–718 doi:10.1038/ng.156.
136. [136] Loos, R.J.F., Lindgren, C.M., Li, S., Wheeler, E., Zhao, J.H., Prokopenko, I., Inouye, M., Freathy, R.M., Attwood, A.P., Beckmann, J.S., Berndt, S.I., Jacobs, K.B., Chanock, S.J., Hayes, R.B., Bergmann, S., Bennett, A.J., Bingham, S.A., Bochud, M., Brown, M., Cauchi, S., Connell, J.M., Cooper, C., Smith, G.D., Day, I., Dina, C., De, S., Dermitzakis, E.T., Doney, A.S.F., Elliott, K.S., Elliott, P., Evans, D.M., Sadaf Farooqi, I., Froguel, P., Ghori, J., Groves, C.J., Gwilliam, R., Hadley, D., Hall, A.S., Hattersley, A.T., Hebebrand, J., Heid, I.M., Lamina, C., Gieger, C., Illig, T., Meitinger, T., Wichmann, H.-E., Herrera, B., Hinney, A., Hunt, S.E., Jarvelin, M.-R., Johnson, T., Jolley, J.D.M., Karpe, F., Keniry, A., Khaw, K.-T., Luben, R.N., Mangino, M., Marchini, J., McArdle, W.L., McGinnis, R., Meyre, D., Munroe, P.B., Morris, A.D., Ness, A.R., Neville, M.J., Nica, A.C., Ong, K.K., O'Rahilly, S., Owen, K.R., Palmer, C.N.A., Papadakis, K., Potter, S., Pouta, A., Qi, L., Kraft, P., Hankinson, S.E., Hunter, D.J., Hu, F.B., Randall, J.C., Rayner, N.W., Ring, S.M., Sandhu, M.S., Scherag, A., Sims, M.A., Song, K., Soranzo, N., Speliotes, E.K., Lyon, H.N., Voight, B.F., Ridderstrale, M., Groop, L., Syddall, H.E., Teichmann, S.A., Timpson, N.J., Tobias, J.H., Uda, M., Scheet, P., Sanna, S., Abecasis, G.R., Albai, G., Nagaraja, R., Schlessinger, D., Ganz Vogel, C.I., Wallace, C., Waterworth, D.M., Weedon, M.N., Willer, C.J., Jackson, A.U., Tuomilehto, J., Collins, F.S., Boehnke, M., Mohlke, K.L., Wraight, V.L., Yuan, X., Zeggini, E., Hirschhorn, J.N., Strachan, D.P., Ouwehand, W.H., Caulfield, M.J., Samani, N.J., Frayling, T.M., Vollenweider, P., Waeber, G., Mooser, V., Deloukas, P., McCarthy, M.I., Wareham, N.J., Barroso, I., Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat. Genet. 40 (2008), 768–775 doi:10.1038/ng.140.
137. [137] Gerhard, G.S., Chu, X., Wood, G.C., Gerhard, G.M., Benotti, P., Petrick, A.T., Gabrielsen, J., Strodel, W.E., Still, C.D., Argyropoulos, G., Next-Generation Sequence Analysis of Genes Associated with Obesity and Nonalcoholic Fatty Liver Disease-Related Cirrhosis in Extreme Obesity. Hum. Hered. 75 (2013), 144–151, 10.1159/000351719.
138. [138] Comuzzie, A.G., Cole, S.A., Laston, S.L., Voruganti, V.S., Haack, K., Gibbs, R.A., Butte, N.F., Novel Genetic Loci Identified for the Pathophysiology of Childhood Obesity in the Hispanic Population. PLoS ONE, 7, 2012, e51954, 10.1371/journal.pone.0051954.
139. [139] Durand, E., Boutin, P., Meyre, D., Charles, M.A., Clement, K., Dina, C., Froguel, P., Polymorphisms in the amino acid transporter solute carrier family 6 (neurotransmitter transporter) member 14 gene contribute to polygenic obesity in French Caucasians. Diabetes 53 (2004), 2483–2486.
140. [140] Suviolahti, E., Oksanen, L.J., Ohman, M., Cantor, R.M., Ridderstrale, M., Tuomi, T., Kaprio, J., Rissanen, A., Mustajoki, P., Jousilahti, P., Vartiainen, E., Silander, K., Kilpikari, R., Salomaa, V., Groop, L., Kontula, K., Peltonen, L., Pajukanta, P., The SLC6A14 gene shows evidence of association with obesity. J. Clin. Invest. 112 (2003), 1762–1772 10.1172/JCI17491.
141. [141] Ohman, M., Oksanen, L., Kaprio, J., Koskenvuo, M., Mustajoki, P., Rissanen, A., Salmi, J., Kontula, K., Peltonen, L., Genome-wide scan of obesity in Finnish sibpairs reveals linkage to chromosome Xq24. J. Clin. Endocrinol. Metab. 85 (2000), 3183–3190, 10.1210/jcem.85.9.6797.
142. [142] Wen, W., Cho, Y.-S., Zheng, W., Dorajoo, R., Kato, N., Qi, L., Chen, C.-H., Delahanty, R.J., Okada, Y., Tabara, Y., Gu, D., Zhu, D., Haiman, C.A., Mo, Z., Gao, Y.-T., Saw, S.-M., Go, M.-J., Takeuchi, F., Chang, L.-C., Kokubo, Y., Liang, J., Hao, M., Le Marchand, L., Zhang, Y., Hu, Y., Wong, T.-Y., Long, J., Han, B.-G., Kubo, M., Yamamoto, K., Su, M.-H., Miki, T., Henderson, B.E., Song, H., Tan, A., He, J., Ng, D.P.-K., Cai, Q., Tsunoda, T., Tsai, F.-J., Iwai, N., Chen, G.K., Shi, J., Xu, J., Sim, X., Xiang, Y.-B., Maeda, S., Ong, R.T.H., Li, C., Nakamura, Y., Aung, T., Kamatani, N., Liu, J.-J., Lu, W., Yokota, M., Seielstad, M., Fann, C.S.J., Wu, J.-Y., Lee, J.-Y., Hu, F.B., Tanaka, T., Tai, E.S., Shu, X.-O., Meta-analysis identifies common variants associated with body mass index in east Asians. Nat. Genet. 44 (2012), 307–311 doi:10.1038/ng.1087.
143. [143] Speliotes, E.K., Willer, C.J., Berndt, S.I., Monda, K.L., Thorleifsson, G., Jackson, A.U., Allen, H.L., Lindgren, C.M., an Luan, J., Mägi, R., Randall, J.C., Vedantam, S., Winkler, T.W., Qi, L., Workalemahu, T., Heid, I.M., Steinthorsdottir, V., Stringham, H.M., Weedon, M.N., Wheeler, E., Wood, A.R., Ferreira, T., Weyant, R.J., Segrè, A.V., Estrada, K., Liang, L., Nemesh, J., Park, J.-H., Gustafsson, S., Kilpeläinen, T.O., Yang, J., Bouatia-Naji, N., Esko, T., Feitosa, M.F., Kutalik, Z., Mangino, M., Raychaudhuri, S., Scherag, A., Smith, A.V., Welch, R., Zhao, J.H., Aben, K.K., Absher, D.M., Amin, N., Dixon, A.L., Fisher, E., Glazer, N.L., Goddard, M.E., Heard-Costa, N.L., Hoesel, V., Hottenga, J.-J., Johansson, Å., Johnson, T., Ketkar, S., Lamina, C., Li, S., Moffatt, M.F., Myers, R.H., Narisu, N., Perry, J.R.B., Peters, M.J., Preuss, M., Ripatti, S., Rivadeneira, F., Sandholt, C., Scott, L.J., Timpson, N.J., Tyrer, J.P., van Wingerden, S., Watanabe, R.M., White, C.C., Wiklund, F., Barlassina, C., Chasman, D.I., Cooper, M.N., Jansson, J.-O., Lawrence, R.W., Pellikka, N., Prokopenko, I., Shi, J., Thiering, E., Alavere, H., Alibrandi, M.T.S., Almgren, P., Arnold, A.M., Aspelund, T., Atwood, L.D., Balkau, B., Balmforth, A.J., Bennett, A.J., Ben-Shlomo, Y., Bergman, R.N., Bergmann, S., Biebermann, H., Blakemore, A.I.F., Boes, T., Bonnycastle, L.L., Bornstein, S.R., Brown, M.J., Buchanan, T.A., Busonero, F., Campbell, H., Cappuccio, F.P., Cavalcanti-Proença, C., Chen, Y.-D.I., Chen, C.-M., Chines, P.S., Clarke, R., Coin, L., Connell, J., Day, I.N.M., den Heijer, M., Duan, J., Ebrahim, S., Elliott, P., Elosua, R., Eiriksdottir, G., Erdos, M.R., Eriksson, J.G., Facheris, M.F., Felix, S.B., Fischer-Posovszky, P., Folsom, A.R., Friedrich, N., Freimer, N.B., Fu, M., Gaget, S., Gejman, P.V., Geus, E.J.C., Gieger, C., Gjesing, A.P., Goel, A., Goyette, P., Grallert, H., Gräßler, J., Greenawalt, D.M., Groves, C.J., Gudnason, V., Guiducci, C., Hartikainen, A.-L., Hassanali, N., Hall, A.S., Havulinna, A.S., Hayward, C., Heath, A.C., Hengstenberg, C., Hicks, A.A., Hinney, A., Hofman, A., Homuth, G., Hui, J., Igl, W., Iribarren, C., Isomaa, B., Jacobs, K.B., Jarick, I., Jewell, E., John, U., Jørgensen, T., Jousilahti, P., Jula, A., Kaakinen, M., Kajantie, E., Kaplan, L.M., Kathiresan, S., Kettunen, J., Kinnunen, L., Knowles, J.W., Kolcic, I., König, I.R., Koskinen, S., Kovacs, P., Kuusisto, J., Kraft, P., Kvaløy, K., Laitinen, J., Lantieri, O., Lanzani, C., Launer, L.J., Lecoeur, C., Lehtimäki, T., Lettre, G., Liu, J., Lokki, M.-L., Lorentzon, M., Luben, R.N., Ludwig, B., Manunta, P., Marek, D., Marre, M., Martin, N.G., McArdle, W.L., McCarthy, A., McKnight, B., Meitinger, T., Melander, O., Meyre, D., Midthjell, K., Montgomery, G.W., Morken, M.A., Morris, A.P., Mulic, R., Ngwa, J.S., Nelis, M., Neville, M.J., Nyholt, D.R., O'Donnell, C.J., O'Rahilly, S., Ong, K.K., Oostra, B., Paré, G., Parker, A.N., Perola, M., Pichler, I., Pietiläinen, K.H., Platou, C.G.P., Polasek, O., Pouta, A., Rafelt, S., Raitakari, O., Rayner, N.W., Ridderstråle, M., Rief, W., Ruokonen, A., Robertson, N.R., Rzehak, P., Salomaa, V., Sanders, A.R., Sandhu, M.S., Sanna, S., Saramies, J., Savolainen, M.J., Scherag, S., Schipf, S., Schreiber, S., Schunkert, H., Silander, K., Sinisalo, J., Siscovick, D.S., Smit, J.H., Soranzo, N., Sovio, U., Stephens, J., Surakka, I., Swift, A.J., Tammesoo, M.-L., Tardif, J.-C., Teder-Laving, M., Teslovich, T.M., Thompson, J.R., Thomson, B., Tönjes, A., Tuomi, T., van Meurs, J.B.J., van Ommen, G.-J., Vatin, V., Viikari, J., Visvikis-Siest, S., Vitart, V., Vogel, C.I.G., Voight, B.F., Waite, L.L., Wallaschofski, H., Walters, G.B., Widen, E., Wiegand, S., Wild, S.H., Willemsen, G., Witte, D.R., Witteman, J.C., Xu, J., Zhang, Q., Zgaga, L., Ziegler, A., Zitting, P., Beilby, J.P., Farooqi, I.S., Hebebrand, J., Huikuri, H.V., James, A.L., Kähönen, M., Levinson, D.F., Macciardi, F., Nieminen, M.S., Ohlsson, C., Palmer, L.J., Ridker, P.M., Stumvoll, M., Beckmann, J.S., Boeing, H., Boerwinkle, E., Boomsma, D.I., Caulfield, M.J., Chanock, S.J., Collins, F.S., Cupples, L.A., Smith, G.D., Erdmann, J., Froguel, P., Grönberg, H., Gyllensten, U., Hall, P., Hansen, T., Harris, T.B., Hattersley, A.T., Hayes, R.B., Heinrich, J., Hu, F.B., Hveem, K., Illig, T., Jarvelin, M.-R., Kaprio, J., Karpe, F., Khaw, K.-T., Kiemeney, L.A., Krude, H., Laakso, M., Lawlor, D.A., Metspalu, A., Munroe, P.B., Ouwehand, W.H., Pedersen, O., Penninx, B.W., Peters, A., Pramstaller, P.P., Quertermous, T., Reinehr, T., Rissanen, A., Rudan, I., Samani, N.J., Schwarz, P.E.H., Shuldiner, A.R., Spector, T.D., Tuomilehto, J., Uda, M., Uitterlinden, A., Valle, T.T., Wabitsch, M., Waeber, G., Wareham, N.J., Watkins, H., Wilson, J.F., Wright, A.F., Zillikens, M.C., Chatterjee, N., McCarroll, S.A., Purcell, S., Schadt, E.E., Visscher, P.M., Assimes, T.L., Borecki, I.B., Deloukas, P., Fox, C.S., Groop, L.C., Haritunians, T., Hunter, D.J., Kaplan, R.C., Mohlke, K.L., O'Connell, J.R., Peltonen, L., Schlessinger, D., Strachan, D.P., van Duijn, C.M., Wichmann, H.-E., Frayling, T.M., Thorsteinsdottir, U., Abecasis, G.R., Barroso, I., Boehnke, M., Stefansson, K., North, K.E.M., McCarthy, I., Hirschhorn, J.N., Ingelsson, E., Loos, R.J.F., Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat. Genet. 42 (2010), 937–948 doi:10.1038/ng.686.
144. [144] Heard-Costa, N.L., Zillikens, M.C., Monda, K.L., Johansson, Å., Harris, T.B., Fu, M., Haritunians, T., Feitosa, M.F., Aspelund, T., Eiriksdottir, G., Garcia, M., Launer, L.J., Smith, A.V., Mitchell, B.D., McArdle, P.F., Shuldiner, A.R., Bielinski, S.J., Boerwinkle, E., Brancati, F., Demerath, E.W., Pankow, J.S., Arnold, A.M., Chen, Y.-D.I., Glazer, N.L., McKnight, B., Psaty, B.M., Rotter, J.I., Amin, N., Campbell, H., Gyllensten, U., Pattaro, C., Pramstaller, P.P., Rudan, I., Struchalin, M., Vitart, V., Gao, X., Kraja, A., Province, M.A., Zhang, Q., Atwood, L.D., Dupuis, J., Hirschhorn, J.N., Jaquish, C.E., O'Donnell, C.J., Vasan, R.S., White, C.C., Aulchenko, Y.S., Estrada, K., Hofman, A., Rivadeneira, F., Uitterlinden, A.G., Witteman, J.C.M., Oostra, B.A., Kaplan, R.C., Gudnason, V., O'Connell, J.R., Borecki, I.B., van Duijn, C.M., Cupples, L.A., Fox, C.S., North, K.E., NRXN3 Is a Novel Locus for Waist Circumference: A Genome-Wide Association Study from the CHARGE Consortium. PLoS Genet., 5, 2009, e1000539, 10.1371/journal.pgen.1000539.
145. [145] Jiao, H., Arner, P., Hoffstedt, J., Brodin, D., Dubern, B., Czernichow, S., van't Hooft, F., Axelsson, T., Pedersen, O., Hansen, T., Sørensen, T.I., Hebebrand, J., Kere, J., Dahlman-Wright, K., Hamsten, A., Clement, K., Dahlman, I., Genome wide association study identifies KCNMA1 contributing to human obesity. BMC Med. Genom., 4, 2011, 51, 10.1186/1755-8794-4-51.
146. [146] Thorleifsson, G., Walters, G.B., Gudbjartsson, D.F., Steinthorsdottir, V., Sulem, P., Helgadottir, A., Styrkarsdottir, U., Gretarsdottir, S., Thorlacius, S., Jonsdottir, I., Jonsdottir, T., Olafsdottir, E.J., Olafsdottir, G.H., Jonsson, T., Jonsson, F., Borch-Johnsen, K., Hansen, T., Andersen, G., Jorgensen, T., Lauritzen, T., Aben, K.K., Verbeek, A.L., Roeleveld, N., Kampman, E., Yanek, L.R., Becker, L.C., Tryggvadottir, L., Rafnar, T., Becker, D.M., Gulcher, J., Kiemeney, L.A., Pedersen, O., Kong, A., Thorsteinsdottir, U., Stefansson, K., Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat. Genet. 41 (2009), 18–24 doi:10.1038/ng.274.
147. [147] Scherag, A., Dina, C., Hinney, A., Vatin, V., Scherag, S., Vogel, C.I.G., Müller, T.D., Grallert, H., Wichmann, H.-E., Balkau, B., Heude, B., Jarvelin, M.-R., Hartikainen, A.-L., Levy-Marchal, C., Weill, J., Delplanque, J., Körner, A., Kiess, W., Kovacs, P., Rayner, N.W., Prokopenko, I., McCarthy, M.I., Schäfer, H., Jarick, I., Boeing, H., Fisher, E., Reinehr, T., Heinrich, J., Rzehak, P., Berdel, D., Borte, M., Biebermann, H., Krude, H., Rosskopf, D., Rimmbach, C., Rief, W., Fromme, T., Klingenspor, M., Schürmann, A., Schulz, N., Nöthen, M.M., Mühleisen, T.W., Erbel, R., Jöckel, K.-H., Moebus, S., Boes, T., Illig, T., Froguel, P., Hebebrand, J., Meyre, D., Two New Loci for Body-Weight Regulation Identified in a Joint Analysis of Genome-Wide Association Studies for Early-Onset Extreme Obesity in French and German Study Groups. PLoS Genet., 6, 2010, e1000916, 10.1371/journal.pgen.1000916.
148. [148] Willer, C.J., Speliotes, E.K., Loos, R.J.F., Li, S., Lindgren, C.M., Heid, I.M., Berndt, S.I., Elliott, A.L., Jackson, A.U., Lamina, C., Lettre, G., Lim, N., Lyon, H.N., McCarroll, S.A., Papadakis, K., Qi, L., Randall, J.C., Roccasecca, R.M., Sanna, S., Scheet, P., Weedon, M.N., Wheeler, E., Zhao, J.H., Jacobs, L.C., Prokopenko, I., Soranzo, N., Tanaka, T., Timpson, N.J., Almgren, P., Bennett, A., Bergman, R.N., Bingham, S.A., Bonnycastle, L.L., Brown, M., Burtt, N.P., Chines, P., Coin, L., Collins, F.S., Connell, J.M., Cooper, C., Smith, G.D., Dennison, E.M., Deodhar, P., Elliott, P., Erdos, M.R., Estrada, K., Evans, D.M., Gianniny, L., Gieger, C., Gillson, C.J., Guiducci, C., Hackett, R., Hadley, D., Hall, A.S., Havulinna, A.S., Hebebrand, J., Hofman, A., Isomaa, B., Jacobs, K.B., Johnson, T., Jousilahti, P., Jovanovic, Z., Khaw, K.-T., Kraft, P., Kuokkanen, M., Kuusisto, J., Laitinen, J., Lakatta, E.G., an Luan, J., Luben, R.N., Mangino, M., McArdle, W.L., Meitinger, T., Mulas, A., Munroe, P.B., Narisu, N., Ness, A.R., Northstone, K., O'Rahilly, S., Purmann, C., Rees, M.G., Ridderstråle, M., Ring, S.M., Rivadeneira, F., Ruokonen, A., Sandhu, M.S., Saramies, J., Scott, L.J., Scuteri, A., Silander, K., Sims, M.A., Song, K., Stephens, J., Stevens, S., Stringham, H.M., Tung, Y.C.L., Valle, T.T., Van Duijn, C.M., Vimaleswaran, K.S., Vollenweider, P., Waeber, G., Wallace, C., Watanabe, R.M., Waterworth, D.M., Watkins, N., Witteman, J.C.M., Zeggini, E., Zhai, G., Zillikens, M.C., Altshuler, D., Caulfield, M.J., Chanock, S.J., Farooqi, I.S., Ferrucci, L., Guralnik, J.M., Hattersley, A.T., Hu, F.B., Jarvelin, M.-R., Laakso, M., Mooser, V., Ong, K.K., Ouwehand, W.H., Salomaa, V., Samani, N.J., Spector, T.D., Tuomi, T., Tuomilehto, J., Uda, M., Uitterlinden, A.G., Wareham, N.J., Deloukas, P., Frayling, T.M., Groop, L.C., Hayes, R.B., Hunter, D.J., Mohlke, K.L., Peltonen, L., Schlessinger, D., Strachan, D.P., Wichmann, H.-E., McCarthy, M.I., Boehnke, M., Barroso, I., Abecasis, G.R., Hirschhorn, J.N., Genetic Investigation of Anthropometric Traits Consortium. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat. Genet. 41 (2009), 25–34 doi:10.1038/ng.287.
149. [149] Farooqi, I.S., O'Rahilly, S., Monogenic human obesity syndromes. Recent Prog, Horm. Res. 59 (2004), 409–424.
150. [150] Farooqi, I.S., Genetic and hereditary aspects of childhood obesity. Best Pract. Res. Clin. Endocrinol. Metab. 19 (2005), 359–374, 10.1016/j.beem.2005.04.004.
151. [151] Krude, H., Biebermann, H., Schnabel, D., Tansek, M.Z., Theunissen, P., Mullis, P.E., Grüters, A., Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10. J. Clin. Endocrinol. Metab. 88 (2003), 4633–4640, 10.1210/jc.2003-030502.
152. [152] Shabana, S., Hasnain, Prevalence of POMC R236G mutation in Pakistan. Obes. Res. Clin. Pract., 2015, 10.1016/j.orcp.2015.10.007.
153. [153] Benzinou, M., Creemers, J.W.M., Choquet, H., Lobbens, S., Dina, C., Durand, E., Guerardel, A., Boutin, P., Jouret, B., Heude, B., Balkau, B., Tichet, J., Marre, M., Potoczna, N., Horber, F., Le Stunff, C., Czernichow, S., Sandbaek, A., Lauritzen, T., Borch-Johnsen, K., Andersen, G., Kiess, W., Körner, A., Kovacs, P., Jacobson, P., Carlsson, L.M.S., Walley, A.J., Jørgensen, T., Hansen, T., Pedersen, O., Meyre, D., Froguel, P., Common nonsynonymous variants in PCSK1 confer risk of obesity. Nat. Genet. 40 (2008), 943–945 doi:10.1038/ng.177.
154. [154] Jackson, R.S., Creemers, J.W.M., Farooqi, I.S., Raffin-Sanson, M.-L., Varro, A., Dockray, G.J., Holst, J.J., Brubaker, P.L., Corvol, P., Polonsky, K.S., Ostrega, D., Becker, K.L., Bertagna, X., Hutton, J.C., White, A., Dattani, M.T., Hussain, K., Middleton, S.J., Nicole, T.M., Milla, P.J., Lindley, K.J., O'Rahilly, S., Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. J. Clin. Invest. 112 (2003), 1550–1560, 10.1172/JCI18784.
155. [155] Jackson, R.S., Creemers, J.W., Ohagi, S., Raffin-Sanson, M.L., Sanders, L., Montague, C.T., Hutton, J.C., O'Rahilly, S., Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat. Genet. 16 (1997), 303–306, 10.1038/ng0797-303.
156. [156] Elias, C.F., Lee, C., Kelly, J., Aschkenasi, C., Ahima, R.S., Couceyro, P.R., Kuhar, M.J., Saper, C.B., Elmquist, J.K., Leptin activates hypothalamic CART neurons projecting to the spinal cord. Neuron 21 (1998), 1375–1385.
157. [157] Schwartz, M.W., Seeley, R.J., Woods, S.C., Weigle, D.S., Campfield, L.A., Burn, P., Baskin, D.G., Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 46 (1997), 2119–2123.
158. [158] Strosberg, A.D., Issad, T., The involvement of leptin in humans revealed by mutations in leptin and leptin receptor genes. Trends Pharmacol. Sci. 20 (1999), 227–230.
159. [159] Clément, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.M., Basdevant, A., Bougnères, P., Lebouc, Y., Froguel, P., Guy-Grand, B., A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392 (1998), 398–401 doi:10.1038/32911.
160. [160] Montague, C.T., Farooqi, I.S., Whitehead, J.P., Soos, M.A., Rau, H., Wareham, N.J., Sewter, C.P., Digby, J.E., Mohammed, S.N., Hurst, J.A., Cheetham, C.H., Earley, A.R., Barnett, A.H., Prins, J.B., O'Rahilly, S., Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387 (1997), 903–908 doi:10.1038/43185.
161. [161] Hastuti, P., Zukhrufia, I., Padwaswari, M.H., Nuraini, A., Sadewa, A.H., Polymorphism in leptin receptor gene was associated with obesity in Yogyakarta, Indonesia. Egypt. J. Med. Hum. Genet. 17 (2016), 271–276, 10.1016/j.ejmhg.2015.12.011.
162. [162] Bray, M.S., Boerwinkle, E., Hanis, C.L., Sequence variation within the neuropeptide Y gene and obesity in Mexican Americans. Obes. Res. 8 (2000), 219–226, 10.1038/oby.2000.25.
163. [163] Ding, B., Kull, B., Liu, Z., Mottagui-Tabar, S., Thonberg, H., Gu, H.F., Brookes, A.J., Grundemar, L., Karlsson, C., Hamsten, A., Arner, P., Ostenson, C.-G., Efendic, S., Monné, M., von Heijne, G., Eriksson, P., Wahlestedt, C., Human neuropeptide Y signal peptide gain-of-function polymorphism is associated with increased body mass index: possible mode of function. Regul. Pept. 127 (2005), 45–53, 10.1016/j.regpep.2004.10.011.
164. [164] Karvonen, M.K., Valkonen, V.P., Lakka, T.A., Salonen, R., Koulu, M., Pesonen, U., Tuomainen, T.P., Kauhanen, J., Nyyssönen, K., Lakka, H.M., Uusitupa, M.I., Salonen, J.T., Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men, Atherosclerosis., 159, 2001, 145–151.
165. [165] Salminen, M., Lehtimäki, T., Fan, Y.-M., Vahlberg, T., Kivelä, S.-L., Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene and changes in serum lipids during a family-based counselling intervention among school-aged children with a family history of CVD. Public Health Nutr., 11, 2008, 10.1017/S1368980008001717.
166. [166] Karvonen, M.K., Koulu, M., Pesonen, U., Uusitupa, M.I., Tammi, A., Viikari, J., Simell, O., Rönnemaa, T., Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with birth weight and serum triglyceride concentration in preschool aged children. J. Clin. Endocrinol. Metab. 85 (2000), 1455–1460, 10.1210/jcem.85.4.6521.
167. [167] van Rossum, C.T.M., Pijl, H., Adan, R.A.H., Hoebee, B., Seidell, J.C., Polymorphisms in the NPY and AGRP genes and body fatness in Dutch adults. Int. J. Obes. (Lond.); 30 (2006), 1522–1528, 10.1038/sj.ijo.0803314.
168. [168] Masoudi-Kazemabad, A., Jamialahmadi, K., Moohebati, M., Mojarrad, M., Manshadi, R.D., Akhlaghi, S., Ferns, G.A., Ghayour-Mobarhan, M., Neuropeptide Y Leu7Pro Polymorphism Associated With the Metabolic Syndrome and Its Features in Patients With Coronary Artery Disease. Angiology 64 (2013), 40–45, 10.1177/0003319711435149.
169. [169] Wang, W., Tao, Y.-X., Ghrelin Receptor Mutations and Human Obesity. Prog. Mol. Biol. Transl. Sci., Elsevier, 2016, 131–150 http://linkinghub.elsevier.com/retrieve/pii/S1877117316000417.
170. [170] Holst, B., Schwartz, T.W., Ghrelin receptor mutations – too little height and too much hunger. J. Clin. Invest. 116 (2006), 637–641, 10.1172/JCI27999.
171. [171] Yang, F., Tao, Y.-X., Functional characterization of nine novel naturally occurring human melanocortin-3 receptor mutations. Biochim. Biophys. Acta 1822 (2012), 1752–1761, 10.1016/j.bbadis.2012.07.017.
172. [172] Lee, Y.-S., Poh, L.K.-S., Loke, K.-Y., A novel melanocortin 3 receptor gene (MC3R) mutation associated with severe obesity. J. Clin. Endocrinol. Metab. 87 (2002), 1423–1426, 10.1210/jcem.87.3.8461.
173. [173] Zegers, D., Beckers, S., de Freitas, F., Peeters, A.V., Mertens, I.L., Verhulst, S.L., Rooman, R.P., Timmermans, J.-P., Desager, K.N., Massa, G., Van Gaal, L.F., Van Hul, W., Identification of Three Novel Genetic Variants in the Melanocortin-3 Receptor of Obese Children. Obesity 19 (2011), 152–159, 10.1038/oby.2010.127.
174. [174] Tao, Y.-X., Functional characterization of novel melanocortin-3 receptor mutations identified from obese subjects. Biochim. Biophys. Acta 1772 (2007), 1167–1174, 10.1016/j.bbadis.2007.09.002.
175. [175] Mencarelli, M., Walker, G.E., Maestrini, S., Alberti, L., Verti, B., Brunani, A., Petroni, M.L., Tagliaferri, M., Liuzzi, A., Di Blasio, A.M., Sporadic mutations in melanocortin receptor 3 in morbid obese individuals. Eur. J. Hum. Genet. 16 (2008), 581–586, 10.1038/sj.ejhg.5202005.
176. [176] Mencarelli, M., Dubern, B., Alili, R., Maestrini, S., Benajiba, L., Tagliaferri, M., Galan, P., Rinaldi, M., Simon, C., Tounian, P., Hercberg, S., Liuzzi, A., Di Blasio, A.M., Clement, K., Rare melanocortin-3 receptor mutations with in vitro functional consequences are associated with human obesity. Hum. Mol. Genet. 20 (2011), 392–399, 10.1093/hmg/ddq472.
177. [177] Cieslak, J., Majewska, K.A., Tomaszewska, A., Skowronska, B., Fichna, P., Switonski, M., Common polymorphism (81Val>Ile); and rare mutations (257Arg>Ser and 335Ile>Ser) of the MC3R gene in obese Polish children and adolescents. Mol Biol Rep. 40 (2013), 6893–6898, 10.1007/s11033-013-2808-8.
178. [178] Yang, F., Huang, H., Tao, Y.-X., Biased Signaling in Naturally Occurring Mutations in Human Melanocortin-3 Receptor Gene. Int. J. Biol. Sci. 11 (2015), 423–433, 10.7150/ijbs.11032.
179. [179] Gantz, I., Fong, T.M., The melanocortin system. Am. J. Physiol. Endocrinol. Metab. 284 (2003), E468–E474, 10.1152/ajpendo.00434.2002.
180. [180] Vaisse, C., Clement, K., Guy-Grand, B., Froguel, P., A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat. Genet. 20 (1998), 113–114 doi:10.1038/2407.
181. [181] Yeo, G.S., Farooqi, I.S., Aminian, S., Halsall, D.J., Stanhope, R.G., O'Rahilly, S., A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat. Genet. 20 (1998), 111–112 doi:10.1038/2404.
182. [182] Qi, L., Kraft, P., Hunter, D.J., Hu, F.B., The common obesity variant near MC4R gene is associated with higher intakes of total energy and dietary fat, weight change and diabetes risk in women, Hum. Mol. Genet. 17 (2008), 3502–3508, 10.1093/hmg/ddn242.
183. [183] Kublaoui, B.M., Zinn, A.R., Editorial: MC4R mutations – weight before screening. J. Clin. Endocrinol. Metab. 91 (2006), 1671–1672, 10.1210/jc.2006-0546.
184. [184] Farooqi, I.S., Keogh, J.M., Yeo, G.S.H., Lank, E.J., Cheetham, T., O'Rahilly, S., Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N. Engl. J. Med. 348 (2003), 1085–1095, 10.1056/NEJMoa022050.
185. [185] Rosmond, R., Chagnon, M., Bouchard, C., Björntorp, P., A missense mutation in the human melanocortin-4 receptor gene in relation to abdominal obesity and salivary cortisol. Diabetologia 44 (2001), 1335–1338, 10.1007/s001250100649.
186. [186] Lv, D., Zhang, D.-D., Wang, H., Zhang, Y., Liang, L., Fu, J.-F., Xiong, F., Liu, G.-L., Gong, C.-X., Luo, F.-H., Chen, S.-K., Li, Z.-L., Zhu, Y.-M., Genetic variations in SEC16B, MC4R, MAP2K5 and KCTD15 were associated with childhood obesity and interacted with dietary behaviors in Chinese school-age population. Gene. 560 (2015), 149–155, 10.1016/j.gene.2015.01.054.
187. [187] Khalilitehrani, A., Qorbani, M., Hosseini, S., Pishva, H., The association of MC4R rs17782313 polymorphism with dietary intake in Iranian adults. Gene. 563 (2015), 125–129, 10.1016/j.gene.2015.03.013.
188. [188] Church, C., Lee, S., Bagg, E.A.L., McTaggart, J.S., Deacon, R., Gerken, T., Lee, A., Moir, L., Mecinović, J., Quwailid, M.M., Schofield, C.J., Ashcroft, F.M., Cox, R.D., A Mouse Model for the Metabolic Effects of the Human Fat Mass and Obesity Associated FTO Gene. PLoS Genet., 5, 2009, e1000599, 10.1371/journal.pgen.1000599.
189. [189] Church, C., Moir, L., McMurray, F., Girard, C., Banks, G.T., Teboul, L., Wells, S., Brüning, J.C., Nolan, P.M., Ashcroft, F.M., Cox, R.D., Over expression of Fto leads to increased food intake and results in obesity. Nat. Genet. 42 (2010), 1086–1092, 10.1038/ng.713.
190. [190] Li, H., Kilpeläinen, T.O., Liu, C., Zhu, J., Liu, Y., Hu, C., Yang, Z., Zhang, W., Bao, W., Cha, S., Wu, Y., Yang, T., Sekine, A., Choi, B.Y., Yajnik, C.S., Zhou, D., Takeuchi, F., Yamamoto, K., Chan, J.C., Mani, K.R., Been, L.F., Imamura, M., Nakashima, E., Lee, N., Fujisawa, T., Karasawa, S., Wen, W., Joglekar, C.V., Lu, W., Chang, Y., Xiang, Y., Gao, Y., Liu, S., Song, Y., Kwak, S.H., Shin, H.D., Park, K.S., Fall, C.H.D., Kim, J.Y., Sham, P.C., Lam, K.S.L., Zheng, W., Shu, X., Deng, H., Ikegami, H., Krishnaveni, G.V., Sanghera, D.K., Chuang, L., Liu, L., Hu, R., Kim, Y., Daimon, M., Hotta, K., Jia, W., Kooner, J.S., Chambers, J.C., Chandak, G.R., Ma, R.C., Maeda, S., Dorajoo, R., Yokota, M., Takayanagi, R., Kato, N., Lin, X., Loos, R.J.F., Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia 55 (2012), 981–995, 10.1007/s00125-011-2370-7.
191. [191] Rees, S.D., Islam, M., Hydrie, M.Z.I., Chaudhary, B., Bellary, S., Hashmi, S., O'Hare, J.P., Kumar, S., Sanghera, D.K., Chaturvedi, N., Barnett, A.H., Shera, A.S., Weedon, M.N., Basit, A., Frayling, T.M., Kelly, M.A., Jafar, T.H., An FTO variant is associated with Type 2 diabetes in South Asian populations after accounting for body mass index and waist circumference. Diabet. Med. 28 (2011), 673–680, 10.1111/j.1464-5491.2011.03257.x.
192. [192] Claussnitzer, M., Dankel, S.N., Kim, K.-H., Quon, G., Meuleman, W., Haugen, C., Glunk, V., Sousa, I.S., Beaudry, J.L., Puviindran, V., Abdennur, N.A., Liu, J., Svensson, P.-A., Hsu, Y.-H., Drucker, D.J., Mellgren, G., Hui, C.-C., Hauner, H., Kellis, M., FTO Obesity Variant Circuitry and Adipocyte Browning in Humans. N. Engl. J. Med. 373 (2015), 895–907, 10.1056/NEJMoa1502214.
193. [193] Wåhlén, K., Sjölin, E., Hoffstedt, J., The common rs9939609 gene variant of the fat mass- and obesity-associated gene FTO is related to fat cell lipolysis. J. Lipid Res. 49 (2008), 607–611, 10.1194/jlr.M700448-JLR200.
194. [194] Shahid, A., Rana, S., Saeed, S., Imran, M., Afzal, N., Mahmood, S., Common variant of FTO gene, rs9939609, and obesity in Pakistani females, Biomed. Res. Int., 2013, 2013, 324093, 10.1155/2013/324093.
195. [195] Kumar, P., Singh, R.K., Mahalingam, K., In silico analysis of fat mass obesity associated (FTO) gene using computational algorithms. Int. J. Pharm. Biol. Sci. 6:B (2015), 589–599.
196. [196] Phani, N.M., Vohra, M., Rajesh, S., Adhikari, P., Nagri, S.K., D'Souza, S.C., Satyamoorthy, K., Rai, P.S., Implications of critical PPARγ2, ADIPOQ and FTO gene polymorphisms in type 2 diabetes and obesity-mediated susceptibility to type 2 diabetes in an Indian population. Mol. Genet. Genomics 291 (2016), 193–204, 10.1007/s00438-015-1097-4.
197. [197] Martins, M.C., Trujillo, J., Farias, D.R., Struchiner, C.J., Kac, G., Association of the FTO (rs9939609) and MC4R (rs17782313) gene polymorphisms with maternal body weight during pregnancy. Nutrition., 2016, 10.1016/j.nut.2016.04.009.
198. [198] Illangasekera, Y.A., Kumarasiri, R.P.V., Fernando, D.J., Dalton, C.F., Association of FTO and near MC4R variants with obesity measures in urban and rural dwelling Sri Lankans. Obes. Res. Clin. Pract., 2016, 10.1016/j.orcp.2016.02.003.
199. [199] Hinney, A., Vogel, C.I.G., Hebebrand, J., From monogenic to polygenic obesity: recent advances. Eur. Child. Adolesc. Psychiatry 19 (2010), 297–310, 10.1007/s00787-010-0096-6.
200. [200] Clément, K., Genetics of human obesity. C. R. Biologies 329 (2006), 608–622, 10.1016/j.crvi.2005.10.009.
201. [201] Hong, S., Dimitrov, S., Pruitt, C., Shaikh, F., Beg, N., Benefit of physical fitness against inflammation in obesity: Role of beta adrenergic receptors. Brain. Behav. Immun. 39 (2014), 113–120, 10.1016/j.bbi.2013.12.009.
202. [202] Pippig, S., Andexinger, S., Daniel, K., Puzicha, M., Caron, M.G., Lefkowitz, R.J., Lohse, M.J., Overexpression of beta-arrestin and beta-adrenergic receptor kinase augment desensitization of beta 2-adrenergic receptors. J. Biol. Chem. 268 (1993), 3201–3208.
203. [203] Rosado, E.L., Bressan, J., Martins, M.F., Cecon, P.R., Martínez, J.A., Polymorphism in the PPARgamma2 and beta2-adrenergic genes and diet lipid effects on body composition, energy expenditure and eating behavior of obese women. Appetite. 49 (2007), 635–643, 10.1016/j.appet.2007.04.003.
204. [204] Lowell, B.B., Bachman, E.S., Adrenergic Receptors, Diet-induced Thermogenesis, and Obesity. J. Biol. Chem. 278 (2003), 29385–29388, 10.1074/jbc.R300011200.
205. [205] Li, S., Chen, W., Srinivasan, S.R., Boerwinkle, E., Berenson, G.S., Influence of lipoprotein lipase gene Ser447Stop and beta1-adrenergic receptor gene Arg389Gly polymorphisms and their interaction on obesity from childhood to adulthood: the Bogalusa Heart Study. Int. J. Obes. (Lond.); 30 (2006), 1183–1188, 10.1038/sj.ijo.0803281.
206. [206] Linné, Y., Dahlman, I., Hoffstedt, J., beta1-Adrenoceptor gene polymorphism predicts long-term changes in body weight. Int. J. Obes. (Lond.); 29 (2005), 458–462, 10.1038/sj.ijo.0802892.
207. [207] Macho-Azcárate, T., Calabuig, J., Martí, A., Martínez, J.A., A maximal effort trial in obese women carrying the beta2-adrenoceptor Gln27Glu polymorphism. J. Physiol. Biochem. 58 (2002), 103–108.
208. [208] Macho-Azcarate, T., Marti, A., González, A., Martinez, J.A., Ibañez, J., Gln27Glu polymorphism in the beta2 adrenergic receptor gene and lipid metabolism during exercise in obese women. Int. J. Obes. Relat. Metab. Disord. 26 (2002), 1434–1441, 10.1038/sj.ijo.0802129.
209. [209] Corbalán, M.S., Marti, A., Forga, L., Martínez-González, M.A., Martínez, J.A., Beta(2)-adrenergic receptor mutation and abdominal obesity risk: effect modification by gender and HDL-cholesterol. Eur. J. Nutr. 41 (2002), 114–118, 10.1007/s00394-002-0363-5.
210. [210] Corbalán, M.S., Marti, A., Forga, L., Martínez-González, M.A., Martínez, J.A., The 27Glu polymorphism of the beta2-adrenergic receptor gene interacts with physical activity influencing obesity risk among female subjects. Clin. Genet. 61 (2002), 305–307.
211. [211] Marti, A., Corbalán, M.S., Martínez-Gonzalez, M.A., Martinez, J.A., TRP64ARG polymorphism of the beta 3-adrenergic receptor gene and obesity risk: effect modification by a sedentary lifestyle. Diabetes Obes. Metab. 4 (2002), 428–430.
212. [212] Ochoa, M.C., Marti, A., Azcona, C., Chueca, M., Oyarzábal, M., Pelach, R., Patiño, A., Moreno-Aliaga, M.J., Martínez-González, M.A., Martínez, J.A., Groupo de Estudio Navarro de Obesidad Infantil (GENOI), Gene–gene interaction between PPAR gamma 2 and ADR beta 3 increases obesity risk in children and adolescents. Int. J. Obes. Relat. Metab. Disord. 28 (2004), S37–S41, 10.1038/sj.ijo.0802803.
213. [213] del Ochoa, M.C., Martí, A., Martínez, J.A., [Obesity studies in candidate genes]. Med. Clin. (Barc.) 122 (2004), 542–551.
214. [214] Park, H.S., Kim, Y., Lee, C., Single nucleotide variants in the beta2-adrenergic and beta3-adrenergic receptor genes explained 18.3% of adolescent obesity variation. J. Hum. Genet. 50 (2005), 365–369, 10.1007/s10038-005-0260-x.
215. [215] Zurbano, R., Ochoa, M.C., Moreno-Aliaga, M.J., Martínez, J.A., Marti, A., Grupo de Estudio Navarro de la obesidad infantil. [Influence of the -866G/A polymorphism of the UCP2 gene on an obese pediatric population]. Nutr. Hosp. 21 (2006), 52–56.
216. [216] Ovesjö, M.L., Gamstedt, M., Collin, M., Meister, B., GABAergic nature of hypothalamic leptin target neurones in the ventromedial arcuate nucleus. J. Neuroendocrinol. 13 (2001), 505–516.
217. [217] Singh, R.K., Kumar, P., Mahalingam, K., In silico analysis of Snps in human obesity related gene, SLC6A14 (solute carrier family 6 (amino acid transporter), member 14). Int. J. Pharm. Biol. Sci. 7:B (2016), 248–256.
218. [218] González-Jiménez, E., Aguilar Cordero, M.J., Padilla López, C.A., García García, I., [Monogenic human obesity: role of the leptin-melanocortin system in the regulation of food intake and body weight in humans]. An. Sist. Sanit. Navar. 35 (2012), 285–293.
219. [219] Goldstone, A.P., Prader-Willi syndrome: advances in genetics, pathophysiology and treatment. Trends Endocrinol. Metab. 15 (2004), 12–20.
220. [220] Rose, E.A., Glaser, T., Jones, C., Smith, C.L., Lewis, W.H., Call, K.M., Minden, M., Champagne, E., Bonetta, L., Yeger, H., Complete physical map of the WAGR region of 11p13 localizes a candidate Wilms’ tumor gene. Cell 60 (1990), 495–508.
221. [221] Faivre, L., Cormier-Daire, V., Lapierre, J.M., Colleaux, L., Jacquemont, S., Geneviéve, D., Saunier, P., Munnich, A., Turleau, C., Romana, S., Prieur, M., De Blois, M.C., Vekemans, M., Deletion of the SIM1 gene (6q16.2) in a patient with a Prader–Willi-like phenotype. J. Med. Genet. 39 (2002), 594–596.
222. [222] Chiang, A.P., Beck, J.S., Yen, H.-J., Tayeh, M.K., Scheetz, T.E., Swiderski, R.E., Nishimura, D.Y., Braun, T.A., Kim, K.-Y.A., Huang, J., Elbedour, K., Carmi, R., Slusarski, D.C., Casavant, T.L., Stone, E.M., Sheffield, V.C., Homozygosity mapping with SNP arrays identifies TRIM32, an E3 ubiquitin ligase, as a Bardet–Biedl syndrome gene (BBS11), Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 6287–6292, 10.1073/pnas.0600158103.
223. [223] Hagerman, P.J., Hagerman, R.J., The fragile-X premutation: a maturing perspective. Am. J. Hum. Genet. 74 (2004), 805–816, 10.1086/386296.
224. [224] Cohen, M.M., Hall, B.D., Smith, D.W., Graham, C.B., Lampert, K.J., A new syndrome with hypotonia, obesity, mental deficiency, and facial, oral, ocular, and limb anomalies. J. Pediatr. 83 (1973), 280–284.
225. [225] Chandler, K.E., Kidd, A., Al-Gazali, L., Kolehmainen, J., Lehesjoki, A.-E., Black, G.C.M., Clayton-Smith, J., Diagnostic criteria, clinical characteristics, and natural history of Cohen syndrome, J. Med. Genet. 40 (2003), 233–241.
226. [226] Herrera, B.M., Keildson, S., Lindgren, C.M., Genetics and epigenetics of obesity. Maturitas 69 (2011), 41–49, 10.1016/j.maturitas.2011.02.018.
227. [227] Gerken, T., Girard, C.A., Tung, Y.-C.L., Webby, C.J., Saudek, V., Hewitson, K.S., Yeo, G.S.H., McDonough, M.A., Cunliffe, S., McNeill, L.A., Galvanovskis, J., Rorsman, P., Robins, P., Prieur, X., Coll, A.P., Ma, M., Jovanovic, Z., Farooqi, I.S., Sedgwick, B., Barroso, I., Lindahl, T., Ponting, C.P., Ashcroft, F.M., O'Rahilly, S., Schofield, C.J., The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 318 (2007), 1469–1472, 10.1126/science.1151710.
228. [228] Widiker, S., Kärst, S., Wagener, A., Brockmann, G.A., High-fat diet leads to a decreased methylation of theMc4r gene in the obese BFMI and the lean B6 mouse lines. J. Appl. Genet. 51 (2010), 193–197, 10.1007/BF03195727.
229. [229] Milagro, F.I., Campión, J., García-Díaz, D.F., Goyenechea, E., Paternain, L., Martínez, J.A., High fat diet-induced obesity modifies the methylation pattern of leptin promoter in rats. J. Physiol. Biochem. 65 (2009), 1–9.